BioMarin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BMRN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Mar 26	SellUS$996,744	C. Guyer	Individual	16,486	US$60.46
26 Feb 26	SellUS$381,937	Gregory Friberg	Individual	6,326	US$60.38
26 Feb 26	SellUS$1,599,103	George Davis	Individual	26,061	US$61.36

Insider Trading Volume

Insider Buying: BMRN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BMRN?
Owner Type	Number of Shares	Ownership Percentage
State or Government	170,918	0.0889%
Individual Insiders	945,287	0.492%
General Public	2,232,847	1.16%
Institutions	188,974,307	98.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 67.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.95%	BlackRock, Inc.	19,129,584	US$1.0b	-13.2%	0.01%
9.43%	The Vanguard Group, Inc.	18,127,847	US$994.9m	-2.45%	0.01%
7.58%	Dodge & Cox	14,572,384	US$799.7m	-0.78%	0.2%
7.57%	PRIMECAP Management Company	14,549,314	US$798.5m	-4.46%	0.55%
3.92%	Norges Bank Investment Management	7,531,080	US$413.3m	268%	0.02%
3.91%	State Street Global Advisors, Inc.	7,523,218	US$412.9m	-14.2%	0.01%
3.41%	AQR Capital Management, LLC	6,567,480	US$360.4m	15.7%	0.19%
3.14%	Viking Global Investors LP	6,036,936	US$331.3m	-27.5%	0.85%
1.91%	Geode Capital Management, LLC	3,674,089	US$201.6m	3.73%	0.01%
1.81%	Millennium Management LLC	3,486,461	US$191.3m	32.2%	0.12%
1.73%	Dimensional Fund Advisors LP	3,321,754	US$182.3m	48%	0.02%
1.56%	Vestal Point Capital, LP	3,000,000	US$164.6m	261%	5.06%
1.48%	UBS Asset Management AG	2,850,446	US$156.4m	9.03%	0.01%
1.32%	Capital Research and Management Company	2,547,287	US$139.8m	0.38%	0.01%
1.2%	Deep Track Capital, LP	2,300,000	US$126.2m	9,150%	2.4%
0.95%	Squarepoint OPS LLC	1,828,344	US$100.3m	31.7%	0.2%
0.95%	FMR LLC	1,820,447	US$99.9m	393%	no data
0.88%	Morgan Stanley	1,693,812	US$93.0m	95.3%	0.01%
0.8%	Northern Trust Global Investments	1,547,965	US$85.0m	-6.88%	0.01%
0.76%	Columbia Management Investment Advisers, LLC	1,465,198	US$80.4m	19.3%	0.02%
0.75%	Qube Research & Technologies Ltd	1,436,639	US$78.8m	452%	0.11%
0.74%	Charles Schwab Investment Management, Inc.	1,423,712	US$78.1m	0%	0.01%
0.74%	Assenagon Asset Management S.A.	1,419,067	US$77.9m	312%	0.1%
0.71%	Citadel Advisors LLC	1,364,691	US$74.9m	243%	0.05%
0.71%	DNB Asset Management AS	1,359,549	US$74.6m	6.69%	0.18%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/21 08:25
End of Day Share Price	2026/04/21 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioMarin Pharmaceutical Inc. is covered by 48 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Ying Huang	Barclays
Eliana Merle	Barclays